Vitrolife AB logo

Vitrolife AB (VTRLY)

Market Closed
2 Jun, 20:00
OTC PINK OTC PINK
$
11. 00
0
0%
$
1.49B Market Cap
64.85 P/E Ratio
0.49% Div Yield
130 Volume
3.48 Eps
$ 11
Previous Close
Add Transaction
Day Range
11 11
Year Range
9.5 18.55
Want to track VTRLY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

VTRLY closed yesterday higher at $11, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, VTRLY stock lost -29.4%.
VTRLY pays dividends to its shareholders, with the most recent payment made on May 27, 2026. The next estimated payment will be in In 11 months on May 27, 2027 for a total of $0.1232.
The last earnings report, released on Apr 22, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -1.36%, based on the last three reports.
Vitrolife AB has completed 1 stock splits, with the recent split occurring on Jun 01, 2018.
The company's stock is traded on one exchange.

VTRLY Chart

People also search for

Rest Ez Inc.
$ 70
0%
Konica Minolta Inc.
$ 3.74
0%
Konica Minolta Inc.
$ 6.56
0%
Medacta Group SA
$ 83.91
0%
Embla Medical Hf Sponsored ADR
$ 3.81
0%

Vitrolife AB (VTRLY) FAQ

What is the stock price today?

The current price is $11.00.

On which exchange is it traded?

Vitrolife AB is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is VTRLY.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.49%.

What is its market cap?

As of today, the market cap is 1.49B.

Has Vitrolife AB ever had a stock split?

Vitrolife AB had 1 splits and the recent split was on Jun 01, 2018.

Vitrolife AB Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Bronwyn Brophy O'Connor CEO
OTC PINK Exchange
92852Y101 CUSIP
SE Country
1,150 Employees
17 May 2024 Last Dividend
1 Jun 2018 Last Split
- IPO Date

Overview

Vitrolife AB (publ) is a pioneering company specializing in offering innovative products and solutions for assisted reproduction. The company's diverse portfolio is designed to support various aspects of the in vitro fertilization (IVF) process, from sperm processing to embryo transfer and cryopreservation. Established in 1994, Vitrolife has its headquarters in Gothenburg, Sweden. Over the years, it has expanded its presence across the globe, operating in regions such as Europe, the Middle East, India, Africa, Asia, Japan, the Pacific, and the Americas, underscoring its commitment to aiding fertility clinics and patients worldwide.

Products and Services

Vitrolife AB (publ) offers a comprehensive range of products and technologies designed to enhance the efficiency and success rates of assisted reproductive treatments. Below is an overview of their key offerings:

  • Sperm Processing - Products aimed at optimizing the preparation of sperm for IVF procedures, ensuring the selection of the highest quality sperm for insemination.
  • Oocyte Retrieval Needles - Specialized needles designed for the safe and effective retrieval of oocytes from the ovaries during IVF treatments.
  • Micromanipulation Pipettes - Precision tools used for intricate procedures such as intracytoplasmic sperm injection (ICSI), crucial for handling and manipulating gametes and embryos at microscopic levels.
  • Time-Lapse Systems - Innovations like the EmbryoScope allow for continuous monitoring of embryo development, providing invaluable insights for selecting the best embryo for transfer.
  • Laser and Imaging Systems - Advanced equipment that aids in embryo biopsy and assessment, enhancing precision and outcomes in preimplantation genetic testing (PGT).
  • IVF Media and Oil - High-quality culture mediums and oils that create an optimal environment for embryo cultivation and development outside the human body.
  • Embryo Transfer - Devices and tools specifically designed to facilitate the gentle and precise transfer of embryos into the uterus, maximizing the chances of successful implantation.
  • Cryopreservation - Solutions for the freezing and thawing of eggs, sperm, and embryos, allowing for their preservation for future use in fertility treatments.
  • Genomics Kits - Advanced testing kits that provide genetic screening of embryos, helping in the selection of embryos with the best potential outcomes.
  • Evaluation Tools for Time-Lapse Systems - Software and other tools that assist in interpreting the data captured by time-lapse systems, enabling a deeper understanding of embryo development patterns.

Contact Information

Address: Gustaf Werners gata 2
Phone: 46 3 17 21 80 00